Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as AnticancerAgentPreeti Patel, Vivek Asati, Balak Das Kurmi et al.|Current Cancer Drug Targets|2022Cited by 40
Novel VEGFR‐2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016–2021)S. Vishakha, Preeti Patel, Kumari Kajal et al.|Chemistry & Biodiversity|2023Cited by 24
An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs(2018-2021)S. Vishakha, Preeti Patel, N. Navneesh et al.|Anti-Cancer Agents in Medicinal Chemistry|2024Cited by 11
Current Trends in the Development of EGFR Inhibitors as Promising AnticancerAgents: Sar and Synthetic Studies from (2010-2020)Sitanshu Mondal, Preeti Patel, Balak Das Kurmi et al.|Current Organic Chemistry|2023Cited by 3